Novartis

Novartis wins approval for first U.S. biosimilar drug
Yahoo/Reuters
Fri, 03/6/15 - 10:01 am
Novartis
FDA
Neupogen
Zarxio
Sandoz
Amgen
Novartis sells its RNAi cast-offs from Alnylam in $35M fire sale to Arrowhead
Fierce Biotech
Thu, 03/5/15 - 08:21 am
Novartis
Alnylam
RNAi
Arrowhead Research
Novartis CEO: We can rebuild our good name after 'reputational hit' in Japan
Fierce Pharma
Tue, 03/3/15 - 01:23 pm
Novartis
Joe Jimenez
Japan
GlaxoSmithKline plc (ADR) And Novartis AG (ADR) Complete Three-Part Deal To Restructure
Bidness Etc.
Mon, 03/2/15 - 08:11 am
Novartis
GSK
M&A
vaccines
oncology
Novartis AG, Amgen, Inc. Tussle Over Neupogen Biosimilar Continues
Bidness Etc.
Sun, 03/1/15 - 11:40 am
Novartis
Amgen
biosimilars
Neupogen
Novartis treatment for vision loss meets goals in study
Yahoo/Reuters
Fri, 02/27/15 - 07:11 pm
Novartis
Alcon
RTH258
wet age-related macular degeneration
Novartis AG (ADR) Ordered To Halt Some Japanese Operations
Bidness Etc.
Fri, 02/27/15 - 02:04 pm
Novartis
Japan
Novartis looks to squelch neuro worries over its would-be cardio blockbuster
Fierce Biotech
Fri, 02/27/15 - 11:37 am
Novartis
LCZ696
Novartis lung cancer drug gets EU recommendation
Yahoo/Reuters
Fri, 02/27/15 - 09:09 am
Novartis
Europe
Zykadia
ALK inhibitors
lung cancer
GSK to be No. 1 vaccine producer when it completes $25B asset swap with Novartis next week
Bizjournals.com
Wed, 02/25/15 - 04:39 pm
GSK
Novartis
vaccines
Pharmacyclics mulls sale; J&J, Novartis interested - Bloomberg
Yahoo/Reuters
Wed, 02/25/15 - 04:27 pm
Pharmacyclics
JNJ
Novartis
M&A
FDA approves Novartis's multiple myeloma drug Farydak
Pharmaceutical Business Review
Wed, 02/25/15 - 10:01 am
Novartis
Farydak
Multiple Myeloma
UK doctors lobby for off-label Avastin use
Medical Marketing and Media
Tue, 02/24/15 - 06:59 pm
UK
Avastin
off-label
Lucentis
wet age-related macular degeneration
Roche
Novartis
FDA approves Novartis drug for bone marrow cancer
Yahoo/AP
Mon, 02/23/15 - 09:14 pm
FDA
Novartis
Multiple Myeloma
Farydak
Novartis AG wins approval to buy GSK cancer drugs with conditions
Yahoo/Reuters
Mon, 02/23/15 - 06:00 pm
Novartis
GSK
cancer
BRAF inhibitor
MEK inhibitor
Novartis leads a $28M round for rare disease biotech Merganser
Fierce Biotech
Thu, 02/19/15 - 09:59 am
Novartis
Novartis Venture Fund
Merganser Biotech
Novartis makes concerted push into Israeli biotech startup scene
Fierce Biotech
Thu, 02/19/15 - 07:51 am
Novartis
Israel
Gamida Cell
BioLineRx
Pharma's top 10 M&A deals of 2014
Fierce Pharma
Thu, 02/19/15 - 07:51 am
M&A
Actavis
Allergan
Forest Labs
GSK
Novartis
Bayer
Merck
Cubist Pharma
Roche
InterMune
Mylan Labs
Abbott Labs
Questcor
Mallinckrodt
Eli Lilly
Sun Pharma
Ranbaxy
Novartis seeks new Israeli technologies
Globes, Israel
Sun, 02/15/15 - 11:55 am
Novartis
Glaxo Tries To Turn A Triple Play
Seeking Alpha
Wed, 02/11/15 - 09:11 am
GSK
COPD
Chiesi
AstraZeneca
Novartis
Biogen Idec

Pages